Noguchi, Emi
Tamura, Kenji
Hattori, Masaya
Horiguchi, Jun
Sato, Nobuaki
Kanatani, Kazumitsu
Matsunaga, Kiyoshi
Iwata, Hiroji
Fujiwara, Yasuhiro
Funding for this research was provided by:
Chugai Pharmaceutical Co., Ltd.
Article History
Received: 29 May 2018
Accepted: 26 June 2018
First Online: 23 July 2018
Compliance with ethical standards
:
: KT and JH declare no conflicts of interest. EN has received honoraria from Chugai and Novartis. MH has received honoraria from Chugai, AstraZeneca, Eli Lilly, Pfizer, Eisai, Daiichi-Sankyo, and Novartis. NS has received remuneration from Chugai, AstraZeneca, Eisai, Pfizer, and Taiho. KK and KM are employees of Chugai. HI has received grants from Chugai, AstraZeneca, Bayer, Eli Lilly, GSK, Kyowa Hakko Kirin, MSD, Novartis, and Pfizer; honoraria from Chugai, AstraZeneca, Eisai, and Pfizer. YF has received grants from Chugai and Takeda; honoraria from Chugai, Astra Zeneca, Daiichi-Sankyo, Eisai, Eli Lilly, Novartis, and Taiho.